Frailty in Older AdultsNCT06849557
Chair-bound Exergaming in Pre-frail/ Frail Older Adults in Nursing Home
A study testing Exergaming in people with Frailty in Older Adults, run by Hong Kong Metropolitan University at 1 site in Hong Kong.
Trial summary
This pilot randomized controlled trial is designed to investigate the effectiveness of chair-bound exergaming on improving physical and cognitive function in pre-frail/ frail nursing home residents Read more about this study
- Who is it for?
- Ages 60 years and older
- Conditions the study is for
- Frailty in Older Adults
- What is being tested?
- Exergaming
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- 1 siteHong Kong
- Study dates
- 7 Apr 2025to Dec 2025
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 60 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- older adults aged 60 years or older living in the nursing homes;
- pre-frail or frail according to the Fried Frailty Phenotypes;
- ability to understand and execute instructions; and
- ability to sit unassisted on a chair or in a wheelchair.
Who cannot join
- no controlled medical diagnosed of severe cardiometabolic, respiratory and musculoskeletal disorders;
- any conditions that hinder the participation of intervention and assessment; and
- being involved in any other clinical trials.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Hong Kong1 site, 1 recruiting
- Recruiting
Hiu Kwong (Tak Yue) Nursing Centre
Kowloon
Leung, 2367 8918
About this study
Official title: Effectiveness of Chair-bound Exergaming on Physical and Cognitive Functions in Pre-frail/ Frail Older Adults in Nursing Home: A Pilot Randomized Controlled Trial
This pilot randomized controlled trial is designed to investigate the effectiveness of chair-bound exergaming on improving physical and cognitive function in pre-frail/ frail nursing home residents
Read the detailed description
Objective To explore the effects of the chair-bound exergaming on the enjoyment of physical activity in in pre-frail/ frail nursing home residents.
To evaluate the effects of the chair-bound exergaming in improving physical and cognitive function in pre-frail/ frail nursing home residents.
Research plan and methodology Thirty nursing home residents will be recruited from the nursing homes.
All the eligible participant will be randomly allocated to either one of the following 2 groups (i) Exergaming (intervention group), or (ii) wait list control.
- Intervention group (exergaming group, ERG) Those allocated to the ERG will receive supervised chair-bound exercise programme for 12 weeks.
- Control group (wait list control, CG) Those allocated to the CG will receive supervised chair-bound exercise programme for 12 weeks after post-assessment.
- Conditions
- Frailty in Older Adults
- Being tested
- Exergaming
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
ExergamingBehavioural
This intervention will last 12 weeks. Frail/ pre-frail participants will engage in supervised chair-bound exergaming.
| Study group | Role | What they receive |
|---|---|---|
| Wait-list Control | No intervention | Wait list control, after post-test, 12 week supervised exercise intervention |
| Exergaming | Experimental | 12-week exergaming intervention Receives: Behavioral: Exergaming |
What is being measured
The primary outcome is the main question the study is designed to answer.
upper extremity endurance
upper extremity endurance measured by arm curl test
Measured: T0: baseline
upper extremity endurance
upper extremity endurance measured by arm curl test
Measured: T1: 6 week
upper extremity endurance
upper extremity endurance measured by arm curl test
Measured: T2: immediately (1 week) after intervention
enjoyment
enjoyment of physical activity measured by Physical Activity Enjoyment Scale (PACES)
Measured: T0: baseline
enjoyment
enjoyment of physical activity measured by Physical Activity Enjoyment Scale (PACES)
Measured: T1: 6 week
enjoyment
enjoyment of physical activity measured by Physical Activity Enjoyment Scale (PACES)
Measured: T2: immediately (1 week) after intervention
Secondary outcomes (16)
upper extremity strength
upper extremity strength measured by handheld dynamometer
Measured: T0: baseline
upper extremity strength
upper extremity strength measured by handheld dynamometer
Measured: T1: 6 week
upper extremity strength
upper extremity strength measured by handheld dynamometer
Measured: T2: immediately (1 week) after intervention
lung capacity
lung capacity measured by peak flow meter
Measured: T0: baseline
lung capacity
lung capacity measured by peak flow meter
Measured: T1: 6 week
lung capacity
lung capacity measured by peak flow meter
Measured: T2: immediately (1 week) after intervention
sitting balance
sitting balance measured by sitting with opened eyes, sitting with closed eyes, sitting with shaking "no" and sitting with lifted leg
Measured: T0: baseline
sitting balance
sitting balance measured by sitting with opened eyes, sitting with closed eyes, sitting with shaking "no" and sitting with lifted leg
Measured: T1: 6 week
sitting balance
sitting balance measured by sitting with opened eyes, sitting with closed eyes, sitting with shaking "no" and sitting with lifted leg
Measured: T2: immediately (1 week) after intervention
feasibility, acceptability and appropriateness of intervention
feasibility, acceptability and appropriateness of intervention measured by questionnaire
Measured: T2: immediately (1 week) after intervention
mental health
mental health measured by Patient Health Questionnaire-4 (PHQ-4), range: 0-12; higher score indicates more psychological distress
Measured: T0: baseline
mental health
mental health measured by Patient Health Questionnaire-4 (PHQ-4), range: 0-12; higher score indicates more psychological distress
Measured: T1: 6 week
mental health
mental health measured by Patient Health Questionnaire-4 (PHQ-4), range: 0-12; higher score indicates more psychological distress
Measured: T2: immediately (1 week) after intervention
cognitive function
cognitive function measured by Montreal Cognitive Assessment (MoCA), range: 0-30; lower score indicates more cognitive impairment.
Measured: T0: baseline
cognitive function
cognitive function measured by Montreal Cognitive Assessment (MoCA), range: 0-30; lower score indicates more cognitive impairment.
Measured: T1: 6 week
cognitive function
cognitive function measured by Montreal Cognitive Assessment (MoCA), range: 0-30; lower score indicates more cognitive impairment.
Measured: T2: immediately (1 week) after intervention
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Feb 2025
- Study start7 Apr 2025
- Primary completionDec 2025 (estimated)
- Study completionDec 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Frailty in Older AdultsStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Hong Kong Metropolitan University
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06849557
- Sponsor's protocol ID
- HE-SF2024/58
- Status last verified
- Jan 2025
- First submitted
- 16 Jan 2025
- Last updated
- 14 May 2025
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 14 May 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effectiveness of Chair-bound Exergaming on Physical and Cognitive Functions in Pre-frail/ Frail Older Adults in Nursing Home: A Pilot Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT06849557
- Acronym / sponsor ID
- HE-SF2024/58
- Conditions
- Frailty in Older Adults
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- Hong Kong Metropolitan UniversityUniversity, hospital or other
- Study start
- 7 Apr 2025 (actual)
- Primary completion
- Dec 2025 (estimated)
- Study completion
- Dec 2025 (estimated)
- First posted
- 27 Feb 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This pilot randomized controlled trial is designed to investigate the effectiveness of chair-bound exergaming on improving physical and cognitive function in pre-frail/ frail nursing home residents
Detailed description
Objective To explore the effects of the chair-bound exergaming on the enjoyment of physical activity in in pre-frail/ frail nursing home residents.
To evaluate the effects of the chair-bound exergaming in improving physical and cognitive function in pre-frail/ frail nursing home residents.
Research plan and methodology Thirty nursing home residents will be recruited from the nursing homes.
All the eligible participant will be randomly allocated to either one of the following 2 groups (i) Exergaming (intervention group), or (ii) wait list control.
- Intervention group (exergaming group, ERG) Those allocated to the ERG will receive supervised chair-bound exercise programme for 12 weeks.
- Control group (wait list control, CG) Those allocated to the CG will receive supervised chair-bound exercise programme for 12 weeks after post-assessment.
Study design
- Primary purpose
- Other
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Wait-list Control | No intervention | –Wait list control, after post-test, 12 week supervised exercise intervention |
| Exergaming | Experimental | Behavioral: Exergaming12-week exergaming intervention |
Who may qualify
- Ages
- 60 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- older adults aged 60 years or older living in the nursing homes;
- pre-frail or frail according to the Fried Frailty Phenotypes;
- ability to understand and execute instructions; and
- ability to sit unassisted on a chair or in a wheelchair.
Key exclusion criteria (3 listed)
- no controlled medical diagnosed of severe cardiometabolic, respiratory and musculoskeletal disorders;
- any conditions that hinder the participation of intervention and assessment; and
- being involved in any other clinical trials.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| ExergamingThis intervention will last 12 weeks. Frail/ pre-frail participants will engage in supervised chair-bound exergaming. | Behavioural | Exergaming |
Primary outcome
upper extremity endurance
Time frame: T0: baseline
upper extremity endurance measured by arm curl test
upper extremity endurance
Time frame: T1: 6 week
upper extremity endurance measured by arm curl test
upper extremity endurance
Time frame: T2: immediately (1 week) after intervention
upper extremity endurance measured by arm curl test
enjoyment
Time frame: T0: baseline
enjoyment of physical activity measured by Physical Activity Enjoyment Scale (PACES)
enjoyment
Time frame: T1: 6 week
enjoyment of physical activity measured by Physical Activity Enjoyment Scale (PACES)
enjoyment
Time frame: T2: immediately (1 week) after intervention
enjoyment of physical activity measured by Physical Activity Enjoyment Scale (PACES)
16 secondary outcomes
upper extremity strength
Time frame: T0: baseline
upper extremity strength
Time frame: T1: 6 week
upper extremity strength
Time frame: T2: immediately (1 week) after intervention
lung capacity
Time frame: T0: baseline
lung capacity
Time frame: T1: 6 week
lung capacity
Time frame: T2: immediately (1 week) after intervention
sitting balance
Time frame: T0: baseline
sitting balance
Time frame: T1: 6 week
sitting balance
Time frame: T2: immediately (1 week) after intervention
feasibility, acceptability and appropriateness of intervention
Time frame: T2: immediately (1 week) after intervention
mental health
Time frame: T0: baseline
mental health
Time frame: T1: 6 week
mental health
Time frame: T2: immediately (1 week) after intervention
cognitive function
Time frame: T0: baseline
cognitive function
Time frame: T1: 6 week
cognitive function
Time frame: T2: immediately (1 week) after intervention
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 May 2025.
Related trials for Frailty in Older Adults
Not yet recruiting
Virtual Reality Multidomain Training for Older Adults With Cognitive Frailty
Cognitive Frailty
Not yet recruiting
Eccentric Exercise in Community-dwelling Older Adults
Ageing Well
Not yet recruiting
Effect of Animation-Based Digital Education on Risk Knowledge and Frailty in Older Adults
Aging, Frail Elderly
Active, not recruitingPhase 2
TCM Formula vs. HMB in Pre-Frail Elders: Muscle Strength and Bone Status
Pre-Frailty, Sarcopenia
Recruiting
Perioperative Multicomponent Rehabilitation and Outcomes in Elderly Patients With Frailty
Old Age; Debility, Digestive Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Exergaming in people with Frailty in Older Adults, run by Hong Kong Metropolitan University at 1 site in Hong Kong.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 14 May 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Bonny YM Wong (+852 3970-2976, bymwong@hkmu.edu.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
upper extremity endurance (time frame: T0: baseline). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 May 2025.